Japan’s MHLW To Conduct Avian Flu Vaccines Trials On 6400 People
This article was originally published in PharmAsia News
Japan's Ministry of Health, Labour and Welfare will conduct clinical trials of two kinds of avian flu vaccines on 6,400 people mainly working in medical facilities starting in August. To prepare for the trials, a research team at MHLW has confirmed the implementation methodology with participating medical facilities. If safety and efficacy are confirmed through the trials, MHLW will consider vaccinating about 10 million physicians and other front-line workers prior to a flu pandemic. (Click here for more - Japanese language
You may also be interested in...
The Phase III FIDELIO trial of finerenone has been a success but analysts want to see some actual data before declaring it an unqualified one.
Gilead says remdesivir improved mortality and clinical recovery in COVID-19 patients, but the findings come from a retrospective analysis, not a traditional clinical trial.
Agency resuming domestic inspections with the help of a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.